Addex Therapeutics Ltd
Addex Therapeutics Ltd (0QNV.L) Stock Overview
Explore Addex Therapeutics Ltd’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
1.6M
P/E Ratio
0.67
EPS (TTM)
$-0.53
ROE
0.83%
0QNV.L Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Addex Therapeutics Ltd (0QNV.L) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
The current technical analysis reveals key indicators including an RSI of 47.70, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $0.24.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 0.67 and a market capitalization of 1.6M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.